Request Demo
Last update 24 Jun 2025
CD8+ and CD4+ Donor Memory T-cells-expressing HA1-Specific TCR(HighPass Bio)
Last update 24 Jun 2025
Overview
Basic Info
Drug Type TCR-T Cell therapy |
Synonyms- |
Target- |
Action- |
Mechanism Cell replacements |
Therapeutic Areas |
Active Indication |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
1
Clinical Trials associated with CD8+ and CD4+ Donor Memory T-cells-expressing HA1-Specific TCR(HighPass Bio)NCT03326921
Phase I Study of Adoptive Immunotherapy With CD8+ and CD4+ Memory T Cells Transduced to Express an HA-1-Specific T Cell Receptor (TCR) for Children and Adults With Recurrent Acute Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation (HCT)
100 Clinical Results associated with CD8+ and CD4+ Donor Memory T-cells-expressing HA1-Specific TCR(HighPass Bio)
Login to view more data
100 Translational Medicine associated with CD8+ and CD4+ Donor Memory T-cells-expressing HA1-Specific TCR(HighPass Bio)
Login to view more data
100 Patents (Medical) associated with CD8+ and CD4+ Donor Memory T-cells-expressing HA1-Specific TCR(HighPass Bio)
Login to view more data
100 Deals associated with CD8+ and CD4+ Donor Memory T-cells-expressing HA1-Specific TCR(HighPass Bio)
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Acute Biphenotypic Leukemia | Phase 1 | United States | 23 Feb 2018 | |
| Acute Biphenotypic Leukemia | Phase 1 | United States | 23 Feb 2018 | |
| Acute Myeloid Leukemia | Phase 1 | United States | 23 Feb 2018 | |
| Acute Myeloid Leukemia | Phase 1 | United States | 23 Feb 2018 | |
| Blast Phase Chronic Granulocytic Leukemia | Phase 1 | United States | 23 Feb 2018 | |
| Blast Phase Chronic Granulocytic Leukemia | Phase 1 | United States | 23 Feb 2018 | |
| Blastic Plasmacytoid Dendritic Cell Neoplasm | Phase 1 | United States | 23 Feb 2018 | |
| Blastic Plasmacytoid Dendritic Cell Neoplasm | Phase 1 | United States | 23 Feb 2018 | |
| Chronic Myelomonocytic Leukemia | Phase 1 | United States | 23 Feb 2018 | |
| Chronic Myelomonocytic Leukemia | Phase 1 | United States | 23 Feb 2018 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free